U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 21 to 40 of 40

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hereditary breast/ovarian cancer - analysis the BRCA2 gene mutations in accordance with EMQN recommendations

Laboratory of Human Genetics GENOMED Health Care Center
Poland
61
  • C Sequence analysis of the entire coding region

Hereditary Disease Risk Test

Color Diagnostics, LLC DBA Color Health
United States
5159
  • C Sequence analysis of the entire coding region

Inherited Cancer Panel

Dhiti Omics Technologies Private Ltd
India
13684
  • C Sequence analysis of the entire coding region

OncoGeneDx Custom Panel

GeneDx
United States
10382
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Common Cancer Management Panel

GeneDx
United States
5637
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Management Panel

GeneDx
United States
249
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast/Gyn Cancer Panel

GeneDx
United States
4624
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Common Cancer Panel

GeneDx
United States
6047
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Breast Cancer STAT Panel

Invitae
United States
177
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA 1 and BRCA2 Gene Sequencing

Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences
Iran
42
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Comprehensive BRCA1/BRCA2 Testing

Defense Health Agency Genetics Reference Laboratory United States Air Force
United States
92
  • C Sequence analysis of the entire coding region

Invitae Breast Cancer Guidelines-Based Panel

Invitae
United States
1811
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BROCA

King Laboratory University of Washington
United States
47
  • C Sequence analysis of the entire coding region

BRCA1 and BRCA2 Ashkenazi Founder Mutation

GeneDx
United States
112
  • E Sequence analysis of select exons

BRCA1 and BRCA2 Del/Dup

GeneDx
United States
112
  • D Deletion/duplication analysis

BRCA1 and BRCA2 Sequencing

GeneDx
United States
112
  • C Sequence analysis of the entire coding region

BRCA1/2 Sequencing and Del/Dup Analysis

GeneDx
United States
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Breast and Gyn Cancers Panel

Invitae
United States
3323
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA 1 and BRCA2 Gene Sequencing

Genomic Research Center Shahid Beheshti University of Medical Sciences
Iran
42
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer

Institute of Human Genetics Universitätsmedizin Greifswald
Germany
611
  • D Deletion/duplication analysis

Results: 21 to 40 of 40

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.